Mode
Text Size
Log in / Sign up
N/A N=1,788 Treatment

Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study

Breast Augmentation · Breast Reconstruction · Breast Revision

Enrolled (actual)
1,788
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Local Complications — 12; 7; 8; 2 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Silimed Gel-Filled Mammary Implant (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Tiger Biosciences, LLC.
Primary completion
Dec 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Local Complications
12; 7; 8; 2; 120; 39
SECONDARY
Satisfaction Determined by Patients
414; 110; 58; 20; 444; 121

Summary

Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary augmentation, primary reconstruction, and/or revision of the female breast.

Eligibility Criteria

Inclusion Criteria

Subjects are admitted into the study only if all of the following eligibility is true:

  • Female
  • Age limitation specific to the indication:
  • Primary Augmentation: Must be 18 years or older
  • Primary Reconstruction: No age limit
  • Revision: If original surgery was primary reconstruction, then no age limit. If original surgery was primary augmentation, then must be 18 years or older.
  • Adequate tissue available to cover implant(s)
  • Willingness to follow study requirements (informed consent form, follow-up visits)
  • Candidate for primary augmentation, primary reconstruction, or revision

Exclusion Criteria

Subjects are not eligible if any of the following criteria exist:

  • Advanced fibrocystic disease, considered to be pre-malignant without mastectomy
  • Inadequate or unsuitable tissue
  • Active infection in the body at the time of surgery
  • Pregnant or lactating
  • Medical condition that might result in unduly high surgical risk and/or significant postoperative complications, in the judgment of the Investigator
  • Use of drugs, including any drug that would interfere with blood clotting, that might result in high risk and/or significant postoperative complications
  • Demonstrated psychological characteristics that are unrealistic or unreasonable given the risks involved with the surgical procedure
  • Determination by physical examination that the subject does have any connective tissue/autoimmune disorder
  • Existing carcinoma of the breast without accompanying mastectomy
  • MRI scan is prohibited because of implanted metal device, claustrophobia, or other condition.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00905645). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search